PTC THERAPEUTICS (PTCT) stock: insider trades, news & valuation
Heavy selling
Close · Oct 9, 2026
$64.70
+3.4% on the day
-2.0% over 12 months
52-week range $62.28 – $89.55
Share price and insider trades
PTCT closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$57.9M
Insiders buying0
Insiders selling13
PTC THERAPEUTICS insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 13 sold $57.9M of PTCT stock on the open market.
Get emailed when insiders cluster-buy stocks like PTCT
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
PTCT insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $291K | 4 |
| Q3 2026 | — | 0 | $14.5M | 40 |
| Q2 2026 | — | 0 | $14.2M | 35 |
| Q1 2026 | — | 0 | $9.3M | 62 |
| Q4 2025 | — | 0 | $27.4M | 92 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day1.0×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 PTC THERAPEUTICS, INC. insiders reported open-market purchases totaling $0, while 13 insiders reported sales totaling $57.9M. 233 of 233 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 9 NewSEC | Michael SchmertzlerDirector | Sell Plan | 2,4471,294,147 held (−0%) | $63.38 | $155K | +2.1% | — |
| Oct 9 NewSEC | Michael SchmertzlerDirector | Sell Plan | 531,294,094 held (−0%) | $63.95 | $3K | +1.2% | — |
| Oct 7SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,638105,272 held (−2%) | $64.03 | $105K | +1.0% | — |
| Oct 7SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 435105,272 held (−0%) | $64.16 | $28K | +0.8% | — |
| Oct 2SEC | Glenn Jr Md Phd SteeleDirector | Sell Plan | 12,00022,500 held (−35%) | $65.16 | $782K | -0.7% | — |
| Sep 18SEC | Michael SchmertzlerDirector | Sell Plan | 9,6241,296,970 held (−1%) | $67.83 | $653K | -4.6% | — |
| Sep 18SEC | Michael SchmertzlerDirector | Sell Plan | 7,0061,306,594 held (−1%) | $67.35 | $472K | -3.9% | — |
| Sep 18SEC | Michael SchmertzlerDirector | Sell Plan | 2,9941,313,600 held (−0%) | $66.58 | $199K | -2.8% | — |
| Sep 18SEC | Michael SchmertzlerDirector | Sell Plan | 3761,296,594 held (−0%) | $68.45 | $26K | -5.5% | — |
| Sep 11SEC | Michael SchmertzlerDirector | Sell Plan | 10,0001,316,594 held (−1%) | $67.34 | $673K | -3.9% | — |
| Sep 11SEC | Michael SchmertzlerDirector | Sell Plan | 9,4281,327,166 held (−1%) | $67.79 | $639K | -4.6% | — |
| Sep 11SEC | Michael SchmertzlerDirector | Sell Plan | 5721,326,594 held (−0%) | $68.67 | $39K | -5.8% | — |
| Aug 28SEC | Michael SchmertzlerDirector | Sell Plan | 11,8901,337,204 held (−1%) | $71.55 | $851K | -9.6% | — |
| Aug 28SEC | Michael SchmertzlerDirector | Sell Plan | 6,8741,354,720 held (−1%) | $72.74 | $500K | -11.1% | — |
| Aug 28SEC | Michael SchmertzlerDirector | Sell Plan | 5,6261,349,094 held (−0%) | $73.18 | $412K | -11.6% | — |
| Aug 28SEC | Michael SchmertzlerDirector | Sell Plan | 6101,336,594 held (−0%) | $72.22 | $44K | -10.4% | — |
| Aug 21SEC | Michael SchmertzlerDirector | Sell Plan | 9,4191,364,675 held (−1%) | $70.78 | $667K | -8.6% | — |
| Aug 21SEC | Michael SchmertzlerDirector | Sell Plan | 7,1651,374,094 held (−1%) | $73.67 | $528K | -12.2% | — |
| Aug 21SEC | Michael SchmertzlerDirector | Sell Plan | 5,3351,381,259 held (−0%) | $72.86 | $389K | -11.2% | — |
| Aug 21SEC | Michael SchmertzlerDirector | Sell Plan | 2,3901,362,285 held (−0%) | $71.88 | $172K | -10.0% | — |
| Aug 21SEC | Michael SchmertzlerDirector | Sell Plan | 6911,361,594 held (−0%) | $72.92 | $50K | -11.3% | — |
| Aug 19SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,844106,241 held (−2%) | $72.39 | $133K | -10.6% | — |
| Aug 19SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 969105,272 held (−1%) | $72.90 | $71K | -11.2% | — |
| Aug 6SEC | Matthew B. KleinCEO | Sell Plan | 10,292383,868 held (−3%) | $68.57 | $706K | -5.6% | — |
| Jul 16SEC | Pierre GravierCFO | Sell Plan | 3,49483,986 held (−4%) | $80.35 | $281K | -19.5% | — |
| Jul 13SEC | Mary L. SmithDirector | Sell Plan | 10,00021,813 held (−31%) | $90.00 | $900K | -28.1% | — |
| Jul 13SEC | Mary L. SmithDirector | Sell Plan | 5,83421,813 held (−21%) | $90.00 | $525K | -28.1% | — |
| Jul 13SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 2,46460,299 held (−4%) | $90.25 | $222K | -28.3% | — |
| Jul 8SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 11,36969,587 held (−14%) | $89.03 | $1.0M | -27.3% | — |
| Jul 8SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 10,09060,299 held (−14%) | $86.32 | $871K | -25.0% | — |
| Jul 8SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 9,28860,299 held (−13%) | $89.44 | $831K | -27.7% | — |
| Jul 8SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 8,78670,389 held (−11%) | $85.35 | $750K | -24.2% | — |
| Jul 8SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 3,95680,956 held (−5%) | $87.17 | $345K | -25.8% | — |
| Jul 8SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 2,47460,299 held (−4%) | $87.03 | $215K | -25.7% | — |
| Jul 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,036106,662 held (−1%) | $84.41 | $87K | -23.4% | — |
| Jul 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 833106,392 held (−1%) | $84.41 | $70K | -23.4% | — |
| Jul 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 745105,272 held (−1%) | $86.38 | $64K | -25.1% | — |
| Jul 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 645106,017 held (−1%) | $85.84 | $55K | -24.6% | — |
| Jul 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 601105,272 held (−1%) | $86.38 | $52K | -25.1% | — |
| Jul 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 519105,873 held (−0%) | $85.84 | $45K | -24.6% | — |
| Jul 8SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 42660,684 held (−1%) | $85.28 | $36K | -24.1% | — |
| Jul 8SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 38560,299 held (−1%) | $86.34 | $33K | -25.1% | — |
| Jul 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 387107,698 held (−0%) | $83.10 | $32K | -22.1% | — |
| Jul 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 313107,225 held (−0%) | $83.10 | $26K | -22.1% | — |
| Jun 30SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 7,71860,137 held (−11%) | $85.26 | $658K | -24.1% | — |
| Jun 30SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 41260,137 held (−1%) | $85.23 | $35K | -24.1% | — |
| Jun 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 11,33760,137 held (−16%) | $86.51 | $981K | -25.2% | — |
| Jun 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 8,52271,474 held (−11%) | $85.26 | $727K | -24.1% | — |
| Jun 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 4,92260,137 held (−8%) | $85.03 | $419K | -23.9% | — |
| Jun 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 58260,556 held (−1%) | $85.24 | $50K | -24.1% | — |
| Jun 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 41960,137 held (−1%) | $86.39 | $36K | -25.1% | — |
| Jun 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 40160,137 held (−1%) | $85.01 | $34K | -23.9% | — |
| Jun 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 10060,137 held (−0%) | $87.00 | $9K | -25.6% | — |
| Jun 24SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 12,13071,756 held (−14%) | $80.61 | $978K | -19.7% | — |
| Jun 24SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 11,61960,137 held (−16%) | $81.21 | $944K | -20.3% | — |
| Jun 22SEC | Christine Marie UtterSvp, Chief Accounting Officer | Sell Plan | 19,68670,199 held (−22%) | $75.56 | $1.5M | -14.4% | — |
| Jun 22SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 6,600107,122 held (−6%) | $78.50 | $518K | -17.6% | — |
| Jun 22SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,850105,272 held (−2%) | $79.24 | $147K | -18.3% | — |
| Jun 22SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,703105,581 held (−2%) | $78.50 | $134K | -17.6% | — |
| Jun 22SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 309105,272 held (−0%) | $79.25 | $24K | -18.4% | — |
| Jun 12SEC | Eric PauwelsChief Business Officer | Sell Plan | 17,56673,411 held (−19%) | $75.00 | $1.3M | -13.7% | — |
| Jun 12SEC | Eric PauwelsChief Business Officer | Sell Plan | 3,71173,411 held (−5%) | $75.00 | $278K | -13.7% | — |
| May 19SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 2,356105,668 held (−2%) | $72.08 | $170K | -10.2% | — |
| May 19SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 456105,212 held (−0%) | $72.67 | $33K | -11.0% | — |
| May 15SEC | Matthew B. KleinCEO | Sell Plan | 7,221398,670 held (−2%) | $73.08 | $528K | -11.5% | — |
| May 15SEC | Matthew B. KleinCEO | Sell Plan | 2,572393,998 held (−1%) | $72.46 | $186K | -10.7% | — |
| May 15SEC | Matthew B. KleinCEO | Sell Plan | 2,100396,570 held (−1%) | $73.08 | $153K | -11.5% | — |
| May 15SEC | Matthew B. KleinCEO | Sell Plan | 679405,891 held (−0%) | $73.06 | $50K | -11.4% | — |
| May 12SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,900105,212 held (−2%) | $79.31 | $151K | -18.4% | — |
| May 12SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 840107,112 held (−1%) | $78.23 | $66K | -17.3% | — |
| May 12SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 600105,212 held (−1%) | $79.28 | $48K | -18.4% | — |
| May 12SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 200105,812 held (−0%) | $78.00 | $16K | -17.1% | — |
| Apr 23SEC | Matthew B. KleinCEO | Sell Plan | 2,850394,070 held (−1%) | $70.91 | $202K | -8.8% | — |
| Apr 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,443105,212 held (−1%) | $69.75 | $101K | -7.2% | — |
| Apr 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 822106,655 held (−1%) | $68.91 | $57K | -6.1% | — |
| Apr 6SEC | Lee Scott GoldenEvp & Chief Medical Officer | Sell Plan | 82979,115 held (−1%) | $67.99 | $56K | -4.8% | — |
| Apr 3SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 39,39372,747 held (−35%) | $68.89 | $2.7M | -6.1% | — |
| Apr 3SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 12,53060,217 held (−17%) | $69.50 | $871K | -6.9% | — |
| Apr 3SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 8060,137 held (−0%) | $70.30 | $6K | -8.0% | — |
| Mar 13SEC | Matthew B. KleinCEO | Sell Plan | 2,662396,920 held (−1%) | $64.08 | $171K | +1.0% | — |
| Mar 12SEC | Stephanie OkeyDirector | Sell Plan | 14,0008,000 held (−64%) | $70.00 | $980K | -7.6% | — |
| Mar 12SEC | Stephanie OkeyDirector | Sell Plan | 1,1678,000 held (−13%) | $70.00 | $82K | -7.6% | — |
| Mar 9SEC | Lee Scott GoldenEvp & Chief Medical Officer | Sell Plan | 10,00079,944 held (−11%) | $63.38 | $634K | +2.1% | — |
| Mar 9SEC | Stephanie OkeyDirector | Sell Plan | 6,3338,000 held (−44%) | $63.38 | $401K | +2.1% | — |
| Mar 9SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 3,9892,737 held (−59%) | $63.38 | $253K | +2.1% | — |
| Feb 23SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,629106,014 held (−2%) | $69.82 | $114K | -7.3% | — |
| Feb 23SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 590105,212 held (−1%) | $69.82 | $41K | -7.3% | — |
| Feb 23SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 588107,643 held (−1%) | $68.54 | $40K | -5.6% | — |
| Feb 23SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 212105,802 held (−0%) | $68.54 | $15K | -5.6% | — |
| Feb 20SEC | Matthew B. KleinCEO | Sell Plan | 7,371387,082 held (−2%) | $69.36 | $511K | -6.7% | — |
| Feb 20SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 3,056112,140 held (−3%) | $69.36 | $212K | -6.7% | — |
| Feb 20SEC | Eric PauwelsChief Business Officer | Sell Plan | 3,01977,122 held (−4%) | $69.36 | $209K | -6.7% | — |
| Feb 20SEC | Pierre GravierCFO | Sell Plan | 2,99287,318 held (−3%) | $69.36 | $208K | -6.7% | — |
| Feb 20SEC | Christine Marie UtterSvp, Chief Accounting Officer | Sell Plan | 2,49470,199 held (−3%) | $69.36 | $173K | -6.7% | — |
| Feb 20SEC | Lee Scott GoldenEvp & Chief Medical Officer | Sell Plan | 2,48489,944 held (−3%) | $69.36 | $172K | -6.7% | — |
| Feb 20SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 656,726 held (−1%) | $69.36 | $5K | -6.7% | — |
| Feb 19SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 3,081108,231 held (−3%) | $69.36 | $214K | -6.7% | — |
| Feb 19SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 2,811111,314 held (−2%) | $69.29 | $195K | -6.6% | — |
| Feb 19SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 2111,312 held (−0%) | $70.13 | $140 | -7.7% | — |
| Jan 12SEC | Eric PauwelsChief Business Officer | Sell Plan | 2,56184,928 held (−3%) | $76.42 | $196K | -15.3% | — |
| Jan 12SEC | Matthew B. KleinCEO | Sell Plan | 2,514394,453 held (−1%) | $76.45 | $192K | -15.4% | — |
| Jan 12SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 2,482115,177 held (−2%) | $76.56 | $190K | -15.5% | — |
| Jan 12SEC | Eric PauwelsChief Business Officer | Sell Plan | 1,72281,165 held (−2%) | $77.41 | $133K | -16.4% | — |
| Jan 12SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,521112,105 held (−1%) | $77.46 | $118K | -16.5% | — |
| Jan 12SEC | Eric PauwelsChief Business Officer | Sell Plan | 1,45482,887 held (−2%) | $76.45 | $111K | -15.4% | — |
| Jan 12SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,286113,626 held (−1%) | $76.45 | $98K | -15.4% | — |
| Jan 12SEC | Eric PauwelsChief Business Officer | Sell Plan | 1,02480,141 held (−1%) | $78.70 | $81K | -17.8% | — |
| Jan 12SEC | Christine Marie UtterSvp, Chief Accounting Officer | Sell Plan | 1,03472,693 held (−1%) | $76.45 | $79K | -15.4% | — |
| Jan 12SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 881115,196 held (−1%) | $76.45 | $67K | -15.4% | — |
| Jan 12SEC | Lee Scott GoldenEvp & Chief Medical Officer | Sell Plan | 86692,428 held (−1%) | $76.45 | $66K | -15.4% | — |
| Jan 12SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 686111,419 held (−1%) | $78.71 | $54K | -17.8% | — |
| Jan 12SEC | Eric PauwelsChief Business Officer | Sell Plan | 58784,341 held (−1%) | $76.98 | $45K | -16.0% | — |
| Jan 12SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 265114,912 held (−0%) | $77.07 | $20K | -16.1% | — |
| Jan 12SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 107111,312 held (−0%) | $79.52 | $9K | -18.6% | — |
| Jan 12SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 596,791 held (−1%) | $76.45 | $5K | -15.4% | — |
| Jan 8SEC | Matthew B. KleinCEO | Sell Plan | 5,149399,983 held (−1%) | $76.95 | $396K | -15.9% | — |
| Jan 8SEC | Matthew B. KleinCEO | Sell Plan | 3,016396,967 held (−1%) | $77.48 | $234K | -16.5% | — |
| Jan 8SEC | Pierre GravierCFO | Sell Plan | 2,13990,310 held (−2%) | $76.95 | $165K | -15.9% | — |
| Jan 8SEC | Eric PauwelsChief Business Officer | Sell Plan | 1,78988,841 held (−2%) | $76.95 | $138K | -15.9% | — |
| Jan 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,739119,162 held (−1%) | $76.95 | $134K | -15.9% | — |
| Jan 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,638118,646 held (−1%) | $77.11 | $126K | -16.1% | — |
| Jan 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,503117,659 held (−1%) | $77.48 | $116K | -16.5% | — |
| Jan 8SEC | Christine Marie UtterSvp, Chief Accounting Officer | Sell Plan | 1,38174,962 held (−2%) | $76.95 | $106K | -15.9% | — |
| Jan 8SEC | Eric PauwelsChief Business Officer | Sell Plan | 1,35287,489 held (−2%) | $77.48 | $105K | -16.5% | — |
| Jan 8SEC | Lee Scott GoldenEvp & Chief Medical Officer | Sell Plan | 1,34093,936 held (−1%) | $76.95 | $103K | -15.9% | — |
| Jan 8SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 1,279117,103 held (−1%) | $76.95 | $98K | -15.9% | — |
| Jan 8SEC | Christine Marie UtterSvp, Chief Accounting Officer | Sell Plan | 1,23573,727 held (−2%) | $77.45 | $96K | -16.5% | — |
| Jan 8SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 1,026116,077 held (−1%) | $77.48 | $79K | -16.5% | — |
| Jan 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 949117,697 held (−1%) | $77.91 | $74K | -17.0% | — |
| Jan 8SEC | Lee Scott GoldenEvp & Chief Medical Officer | Sell Plan | 64293,294 held (−1%) | $77.48 | $50K | -16.5% | — |
| Jan 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 471117,939 held (−0%) | $77.10 | $36K | -16.1% | — |
| Jan 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 269117,670 held (−0%) | $77.92 | $21K | -17.0% | — |
| Jan 8SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 546,902 held (−1%) | $76.95 | $4K | -15.9% | — |
| Jan 8SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 526,850 held (−1%) | $77.48 | $4K | -16.5% | — |
| Jan 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 38117,659 held (−0%) | $78.60 | $3K | -17.7% | — |
| Jan 8SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 11117,659 held (−0%) | $78.98 | $869 | -18.1% | — |
| Jan 6SEC | Glenn Jr Md Phd SteeleDirector | Sell Plan | 12,00018,500 held (−39%) | $76.35 | $916K | -15.3% | — |
| Jan 6SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,123122,044 held (−1%) | $74.92 | $84K | -13.6% | — |
| Jan 6SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,035121,009 held (−1%) | $76.10 | $79K | -15.0% | — |
| Jan 6SEC | Emma ReeveDirector | Sell Plan | 73410,666 held (−6%) | $76.00 | $56K | -14.9% | — |
| Jan 6SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 108120,901 held (−0%) | $76.79 | $8K | -15.7% | — |
| Jan 2SEC | Matthew B. KleinCEO | Sell Plan | 8,089341,875 held (−2%) | $76.64 | $620K | -15.6% | — |
| Dec 23SEC | Eric PauwelsChief Business Officer | Sell Plan | 10,54873,593 held (−13%) | $77.55 | $818K | -16.6% | — |
| Dec 23SEC | Eric PauwelsChief Business Officer | Sell Plan | 4,53784,141 held (−5%) | $76.33 | $346K | -15.2% | — |
| Dec 23SEC | Eric PauwelsChief Business Officer | Sell Plan | 3,22070,373 held (−4%) | $78.33 | $252K | -17.4% | — |
| Dec 23SEC | Eric PauwelsChief Business Officer | Sell Plan | 1,50088,678 held (−2%) | $75.77 | $114K | -14.6% | — |
| Dec 23SEC | Eric PauwelsChief Business Officer | Sell Plan | 31370,432 held (−0%) | $77.73 | $24K | -16.8% | — |
| Dec 23SEC | Eric PauwelsChief Business Officer | Sell Plan | 19370,745 held (−0%) | $75.45 | $15K | -14.2% | — |
| Dec 23SEC | Eric PauwelsChief Business Officer | Sell Plan | 5970,373 held (−0%) | $78.43 | $5K | -17.5% | — |
| Dec 23SEC | Eric PauwelsChief Business Officer | Sell Plan | 5970,373 held (−0%) | $78.01 | $5K | -17.1% | — |
| Dec 23SEC | Eric PauwelsChief Business Officer | Sell Plan | 4270,432 held (−0%) | $77.26 | $3K | -16.3% | — |
| Dec 23SEC | Eric PauwelsChief Business Officer | Sell Plan | 3770,474 held (−0%) | $75.66 | $3K | -14.5% | — |
| Dec 19SEC | Eric PauwelsChief Business Officer | Sell Plan | 35,26170,473 held (−33%) | $75.44 | $2.7M | -14.2% | — |
| Dec 19SEC | Eric PauwelsChief Business Officer | Sell Plan | 3,58470,473 held (−5%) | $75.31 | $270K | -14.1% | — |
| Dec 19SEC | Eric PauwelsChief Business Officer | Sell Plan | 2,83170,373 held (−4%) | $75.07 | $213K | -13.8% | — |
| Dec 19SEC | Eric PauwelsChief Business Officer | Sell Plan | 1,24572,912 held (−2%) | $75.28 | $94K | -14.1% | — |
| Dec 19SEC | Eric PauwelsChief Business Officer | Sell Plan | 25170,373 held (−0%) | $75.00 | $19K | -13.7% | — |
| Dec 19SEC | Eric PauwelsChief Business Officer | Sell Plan | 12070,373 held (−0%) | $75.02 | $9K | -13.8% | — |
| Dec 19SEC | Eric PauwelsChief Business Officer | Sell Plan | 10070,373 held (−0%) | $76.00 | $8K | -14.9% | — |
| Dec 19SEC | Eric PauwelsChief Business Officer | Sell Plan | 10070,373 held (−0%) | $76.00 | $8K | -14.9% | — |
| Dec 5SEC | Emma ReeveDirector | Sell Plan | 7336,666 held (−10%) | $78.62 | $58K | -17.7% | — |
| Dec 3SEC | Matthew B. KleinCEO | Sell Plan | 3,428349,964 held (−1%) | $79.07 | $271K | -18.2% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 21,844112,891 held (−16%) | $83.33 | $1.8M | -22.4% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 21,206100,625 held (−17%) | $80.19 | $1.7M | -19.3% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 13,514134,735 held (−9%) | $82.55 | $1.1M | -21.6% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 9,171103,720 held (−8%) | $84.42 | $774K | -23.4% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 6,101100,625 held (−6%) | $80.17 | $489K | -19.3% | — |
| Nov 26SEC | Allan Steven JacobsonDirector | Sell Plan | 6,10017,451 held (−26%) | $80.15 | $489K | -19.3% | — |
| Nov 26SEC | Allan Steven JacobsonDirector | Sell Plan | 5,70117,451 held (−25%) | $80.13 | $457K | -19.3% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 4,834103,446 held (−4%) | $83.39 | $403K | -22.4% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 4,715100,625 held (−4%) | $80.15 | $378K | -19.3% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 3,744108,280 held (−3%) | $82.61 | $309K | -21.7% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 3,663102,582 held (−3%) | $83.41 | $306K | -22.4% | — |
| Nov 26SEC | Allan Steven JacobsonDirector | Sell Plan | 3,50219,389 held (−15%) | $83.38 | $292K | -22.4% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 3,095100,625 held (−3%) | $85.15 | $264K | -24.0% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 2,790106,245 held (−3%) | $82.82 | $231K | -21.9% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 2,621100,825 held (−3%) | $84.54 | $222K | -23.5% | — |
| Nov 26SEC | Allan Steven JacobsonDirector | Sell Plan | 2,51018,976 held (−12%) | $83.93 | $211K | -22.9% | — |
| Nov 26SEC | Allan Steven JacobsonDirector | Sell Plan | 2,46022,891 held (−10%) | $82.58 | $203K | -21.7% | — |
| Nov 26SEC | Allan Steven JacobsonDirector | Sell Plan | 2,26421,486 held (−10%) | $82.63 | $187K | -21.7% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 1,900100,625 held (−2%) | $80.14 | $152K | -19.3% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 1,757100,825 held (−2%) | $84.56 | $149K | -23.5% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 1,650100,625 held (−2%) | $80.14 | $132K | -19.3% | — |
| Nov 26SEC | Allan Steven JacobsonDirector | Sell Plan | 1,23818,151 held (−6%) | $84.47 | $105K | -23.4% | — |
| Nov 26SEC | Allan Steven JacobsonDirector | Sell Plan | 1,12517,851 held (−6%) | $84.45 | $95K | -23.4% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 990101,199 held (−1%) | $83.44 | $83K | -22.5% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 911102,189 held (−1%) | $82.63 | $75K | -21.7% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 862101,094 held (−1%) | $83.35 | $72K | -22.4% | — |
| Nov 26SEC | Allan Steven JacobsonDirector | Sell Plan | 70017,451 held (−4%) | $85.32 | $60K | -24.2% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 689101,956 held (−1%) | $82.63 | $57K | -21.7% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 574100,625 held (−1%) | $84.67 | $49K | -23.6% | — |
| Nov 26SEC | Allan Steven JacobsonDirector | Sell Plan | 40017,451 held (−2%) | $85.24 | $34K | -24.1% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 289100,805 held (−0%) | $84.61 | $24K | -23.5% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 200100,625 held (−0%) | $85.37 | $17K | -24.2% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 200100,625 held (−0%) | $85.34 | $17K | -24.2% | — |
| Nov 26SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 180100,625 held (−0%) | $85.17 | $15K | -24.0% | — |
| Nov 25SEC | Emma ReeveDirector | Sell Plan | 10,0006,666 held (−60%) | $79.50 | $795K | -18.6% | — |
| Nov 19SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,843104,870 held (−2%) | $75.64 | $139K | -14.5% | — |
| Nov 19SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 777104,093 held (−1%) | $76.53 | $59K | -15.5% | — |
| Nov 19SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 192103,901 held (−0%) | $77.18 | $15K | -16.2% | — |
| Nov 14SEC | Emma ReeveDirector | Sell Plan | 7,3336,666 held (−52%) | $74.50 | $546K | -13.2% | — |
| Oct 31SEC | Emma ReeveDirector | Sell Plan | 12,0006,666 held (−64%) | $69.50 | $834K | -6.9% | — |
| Oct 31SEC | Emma ReeveDirector | Sell Plan | 3,6666,666 held (−35%) | $69.50 | $255K | -6.9% | — |
| Oct 9SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,757105,519 held (−2%) | $62.89 | $110K | +2.9% | — |
| Oct 9SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,306104,213 held (−1%) | $63.80 | $83K | +1.4% | — |
| Oct 9SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 312103,901 held (−0%) | $64.97 | $20K | -0.4% | — |
| Oct 7SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 23,863104,901 held (−19%) | $66.45 | $1.6M | -2.6% | — |
| Oct 7SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 23,419128,764 held (−15%) | $65.45 | $1.5M | -1.1% | — |
| Oct 7SEC | Allan Steven JacobsonDirector | Sell Plan | 12,00017,451 held (−41%) | $65.00 | $780K | -0.5% | — |
| Oct 7SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 7,400105,401 held (−7%) | $66.44 | $492K | -2.6% | — |
| Oct 7SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 6,124112,801 held (−5%) | $65.47 | $401K | -1.2% | — |
| Oct 7SEC | Emma ReeveDirector | Sell Plan | 4,59112,713 held (−27%) | $66.09 | $303K | -2.1% | — |
| Oct 7SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 4,276100,625 held (−4%) | $67.15 | $287K | -3.6% | — |
| Oct 7SEC | Emma ReeveDirector | Sell Plan | 4,03712,216 held (−25%) | $66.10 | $267K | -2.1% | — |
| Oct 7SEC | Emma ReeveDirector | Sell Plan | 3,14911,932 held (−21%) | $66.11 | $208K | -2.1% | — |
| Oct 7SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 3,100118,925 held (−3%) | $64.43 | $200K | +0.4% | — |
| Oct 7SEC | Emma ReeveDirector | Sell Plan | 3,02817,304 held (−15%) | $65.09 | $197K | -0.6% | — |
| Oct 7SEC | Emma ReeveDirector | Sell Plan | 2,72916,253 held (−14%) | $65.05 | $178K | -0.5% | — |
| Oct 7SEC | Emma ReeveDirector | Sell Plan | 2,38110,332 held (−19%) | $66.87 | $159K | -3.2% | — |
| Oct 7SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 2,266103,901 held (−2%) | $65.07 | $147K | -0.6% | — |
| Oct 7SEC | Emma ReeveDirector | Sell Plan | 2,16315,081 held (−13%) | $65.02 | $141K | -0.5% | — |
| Oct 7SEC | Emma ReeveDirector | Sell Plan | 1,88410,332 held (−15%) | $66.89 | $126K | -3.3% | — |
| Oct 7SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 1,760100,698 held (−2%) | $66.56 | $117K | -2.8% | — |
| Oct 7SEC | Emma ReeveDirector | Sell Plan | 1,60010,332 held (−13%) | $66.93 | $107K | -3.3% | — |
| Oct 7SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 1,609102,458 held (−2%) | $65.46 | $105K | -1.2% | — |
| Oct 7SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 1,500103,901 held (−1%) | $67.15 | $101K | -3.6% | — |
| Oct 7SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 906103,901 held (−1%) | $66.63 | $60K | -2.9% | — |
| Oct 7SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 877103,901 held (−1%) | $66.67 | $58K | -3.0% | — |
| Oct 7SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 838104,778 held (−1%) | $65.72 | $55K | -1.6% | — |
| Oct 7SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 824104,807 held (−1%) | $65.73 | $54K | -1.6% | — |
| Oct 7SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 550105,616 held (−1%) | $64.44 | $35K | +0.4% | — |
| Oct 7SEC | Mark Elliott BouldingGeneral Counsel | Sell Plan | 536105,631 held (−1%) | $64.43 | $35K | +0.4% | — |
| Oct 7SEC | Neil Gregory AlmsteadChief Technical Ops Officer | Sell Plan | 73100,625 held (−0%) | $67.16 | $5K | -3.7% | — |
Insiders at PTC THERAPEUTICS, INC.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Neil Gregory AlmsteadChief Technical Ops Officer | — | $26.0M | Jul 13, 2026 | — |
| Eric PauwelsChief Business Officer | — | $7.5M | Jun 12, 2026 | — |
| Michael SchmertzlerDirector | — | $6.5M | Oct 9, 2026 | — |
| Mark Elliott BouldingGeneral Counsel | — | $6.1M | Oct 7, 2026 | — |
| Emma ReeveDirector | — | $4.2M | Jan 6, 2026 | — |
| Matthew B. KleinCEO | — | $4.2M | Aug 6, 2026 | — |
| Allan Steven JacobsonDirector | — | $2.9M | Nov 26, 2025 | — |
| Christine Marie UtterSvp, Chief Accounting Officer | — | $1.9M | Jun 22, 2026 | — |
| Glenn Jr Md Phd SteeleDirector | — | $1.7M | Oct 2, 2026 | — |
| Stephanie OkeyDirector | — | $1.5M | Mar 12, 2026 | — |
| Mary L. SmithDirector | — | $1.4M | Jul 13, 2026 | — |
| Lee Scott GoldenEvp & Chief Medical Officer | — | $1.1M | Apr 6, 2026 | — |
| Pierre GravierCFO | — | $653K | Jul 16, 2026 | — |
PTCT stock: common questions
Are PTC THERAPEUTICS, INC. insiders buying PTCT stock?
In the past 12 months, 0 insiders reported open-market purchases of PTCT worth $0.
Are PTC THERAPEUTICS, INC. insiders selling PTCT stock?
13 insiders reported sales worth $57.9M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is PTCT's 52-week range?
Over the past year PTCT has traded between $62.28 and $89.55. It last closed at $64.70 on Oct 9, 2026.